Last update 01 Nov 2024

AbbVie GK

Subsidiary Company|
Tokyo-to, Japan
|
www.abbvie.co.jp

Overview

Tags

Other Diseases
Congenital Disorders
Skin and Musculoskeletal Diseases
Small molecule drug
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases2
Immune System Diseases2
Endocrinology and Metabolic Disease1
Hemic and Lymphatic Diseases1
Nervous System Diseases1
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug2
Monoclonal antibody1
Top 5 TargetCount
JAK1 x JAK2 x JAK3 x TYK21
SERT(Serotonin transporter)1
TNF-α(Tumor necrosis factor α)1

Related

3
Drugs associated with AbbVie GK
Upadacitinib hemihydrate
Target
JAK1 x JAK2 x JAK3 x TYK2
Mechanism
JAK1 inhibitors [+3]
Active Org.
AbbVie Deutschland GmbH & Co. KG [+6]
Originator Org.
AbbVie, Inc.AbbVie, Inc.
Active Indication
Polyarticular Juvenile Idiopathic Arthritis [+22]
Inactive Indication
Dyssomnias
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date16 Aug 2019
Adalimumab
Target
TNF-α
Mechanism
TNF-α inhibitors
Active Org.
AbbVie (Pty) Ltd. (South Africa) [+3]
Originator Org.
AbbVie, Inc.AbbVie, Inc.
Active Indication
Pyoderma Gangrenosum [+17]
Inactive Indication
Axial Spondyloarthritis [+15]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date31 Dec 2002
Fluvoxamine Maleate
Target
SERT
Mechanism
Serotonin reuptake inhibitors
Active Org.
AbbVie GK [+6]
Originator Org.
Solvay SASolvay SA
Active Indication
Phobia, Social [+2]
Inactive Indication
Anxiety Disorders [+5]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CH
First Approval Date01 Jan 1983
31
Clinical Trials associated with AbbVie GK
JPRN-UMIN000050967 / Recruiting
The frequency of uMRD in Japanese patients with CLL after 24 months of treatment with Venetoclax plus/minus Rituximab in the 2L+ in the real-world setting - Japan CLL-MRD study
JPRN-UMIN000050247 / Completed
Real-world experience of venetoclax for patients with newly diagnosed acute myeloid leukemia in Japan: a Multicenter Observational Study - VENUS study
JPRN-jRCTs051220105 / RecruitingPhase 4IIT
Immune response to adjuvanted recombinant zoster vaccine in Japanese RA patients treated with upadacitinib - End Zoster-J study
100 Clinical Results associated with AbbVie GK
Login to view more data
0 Patents (Medical) associated with AbbVie GK
Login to view more data
100 Deals associated with AbbVie GK
Login to view more data
100 Translational Medicine associated with AbbVie GK
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
3
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free